Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shulman

Showing results (1-10 of 282) with videos related to

Pageof 29
Sort By:
Current Oncology Reports|October 12, 2001
What is the ideal duration of adjuvant therapy for primary breast cancer: are four cycles of cyclophosphamide and doxorubicin enough?L N Shulman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
The effect of accountable care organizations on oncology practiceLawrence N Shulman
Journal of the American Optometric Association|February 1, 1976
Optometric manpower development and utilization: a look toward the futureA N Shulman
Hematology/Oncology Clinics of North America|April 1, 1993
The biology of alkylating-agent cellular injuryL N Shulman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Efficient and effective models for integrating advanced practice professionals into oncology practiceLawrence N Shulman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Cancer care quality: current state and future directionsLawrence N Shulman
Current Opinion in Oncology|September 1, 1995
Current role of radiotherapy in Hodgkin's and non-Hodgkin's lymphomaL N Shulman, P M Mauch
Oncology (Williston Park, N.Y.)|February 8, 2011
Will we be able to care for cancer patients in the future?Craig A Bunnell, Lawrence N Shulman
The Journal of Laboratory and Clinical Medicine|September 1, 1977
Maintenance of hemopoietic stem cells in diffusion chamber culturesL N Shulman, S H Robinson
The Lancet. Oncology|January 5, 2017
Follow-up care of cancer survivors: challenges and solutionsLinda A Jacobs, Lawrence N Shulman
Pageof 29

Showing results (1-10 of 282) with videos related to

Sort By:
Pageof 29
Current Oncology Reports|October 12, 2001
What is the ideal duration of adjuvant therapy for primary breast cancer: are four cycles of cyclophosphamide and doxorubicin enough?L N Shulman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
The effect of accountable care organizations on oncology practiceLawrence N Shulman
Journal of the American Optometric Association|February 1, 1976
Optometric manpower development and utilization: a look toward the futureA N Shulman
Hematology/Oncology Clinics of North America|April 1, 1993
The biology of alkylating-agent cellular injuryL N Shulman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Efficient and effective models for integrating advanced practice professionals into oncology practiceLawrence N Shulman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Cancer care quality: current state and future directionsLawrence N Shulman
Current Opinion in Oncology|September 1, 1995
Current role of radiotherapy in Hodgkin's and non-Hodgkin's lymphomaL N Shulman, P M Mauch
Oncology (Williston Park, N.Y.)|February 8, 2011
Will we be able to care for cancer patients in the future?Craig A Bunnell, Lawrence N Shulman
The Journal of Laboratory and Clinical Medicine|September 1, 1977
Maintenance of hemopoietic stem cells in diffusion chamber culturesL N Shulman, S H Robinson
The Lancet. Oncology|January 5, 2017
Follow-up care of cancer survivors: challenges and solutionsLinda A Jacobs, Lawrence N Shulman
Pageof 29